The cholesterol shot you couldn’t afford is now a pill

The FDA approved Merck’s Lipfendra, a daily pill designed to lower cholesterol levels significantly further than is possible with statins. This new medication is specifically cleared for patients whose artery-clogging cholesterol remains high despite the use of cheap cholesterol-reducing pills. By providing a pill alternative to previous expensive shots, Lipfendra offers a new treatment option for managing severe cholesterol levels that do not respond sufficiently to standard statin therapy as reported by the FDA.